Shanghai BDgene Co., Ltd.
Shanghai BDgene Co., Ltd.
Explore linked clinical trials.5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis | Herpes Simplex Virus Type I Stromal Keratitis | Recruiting | Phase 2 | 2025-05-18 | NCT06474442 | |
| A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis | DNA Virus Infections, Herpesviridae infectious disease, Infections, Keratitis, Herpetic, corneal disorder, eye disorder, eye infectious disorder, herpes simplex infectious disease, keratitis, viral eye infection, viral infectious disease | Active, not recruiting | Phase 1 | 2025-05-18 | NCT06474416 | |
| A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major | β-thalassemia | Recruiting | Phase 1 | 2024-06-24 | NCT06465550 | |
| Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia | β-thalassemia Major | Recruiting | Not applicable | 2024-06-14 | NCT05776173 | |
| Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia | β-thalassemia | Recruiting | Not applicable | 2024-06-14 | NCT05773729 |